Attend a free virtual precision public health webinar on July 27 from 7:00-8:00pm ET/July 28 from 9-10 am AEST. During this time, Dr. Ainsley Newson, Professor of Bioethics at the University of Sydney, will present “Approaches to Ethical Deliberation in Precision Public Health,” which will examine how bioethics scholarship should approach issues related to the use of genetics and genomics in precision public health and the appropriate implementation of these technologies.

This webinar will be held on Zoom. Registration is required.

Register for the upcoming International HundredK+ Cohorts Consortium (IHCC) webinar presented on Tuesday, June 28, 2022 at 8:00am ET/1:30pm UTC. Guest speaker Dr. Reza Malekzadeh will speak on “Using the IHCC to Prevent Premature Death Around the Globe.”

Registration is required.

Dr. Malekzadeh is a Professor at the Digestive Disease Research Institute of Tehran in Iran. He founded the institute in 2000 and has since expanded it further. His main field of interest is digestive oncology and chronic disease with a special interest in prevention of NCD. He has also supervised and conducted several epidemiological and clinical studies and even established the first large-scale cohort study in the Middle East and North Africa (Golestan Cohort Study).

Dr. Malekzadeh is currently a member of 20 large-scale international collaborative studies. Since cardiovascular diseases (CVD), cancers, and other chronic diseases are the leading causes of morbidity and mortality in Iran, he is interested in investigating the environmental and genetic risk factors of chronic diseases as well as metabolic syndrome. For this reason, he has since started the Pars (Southern Iran) and Golestan (Northern Iran) Cohort Studies and several other studies including clinical trials, case control and ecologic studies, collecting detailed data and biological samples from cohort subjects and patients with cancer, CVD, chronic liver disease especially HBV, NAFLD/NASH.

He’s also established a pragmatic randomized control trial of healthy lifestyle and polypill for prevention of CVD and other NCD nested within the Golestan and pars cohort as well as the Persian Cohort, which includes all seven ethnicities of Iran with 200,000-sample size from 20 different provinces.

To learn more about the series, the upcoming webinar, our guest speaker, and to register for this event, please visit the IHCC Educational Webinar Series webpage.

Join Sarah Heston, MD and Nathan Bihlmeyer, PhD on May 26 from 12pm ET – 1pm ET for a discussion on the “Effects of Antibiotic Exposures on the Gut Resistome after Hematopoietic Stem Cell Transplantation in Children” and “Pediatric and Proteins: Unique Biology of Children Undergoing Obesity Interventions and Association to Cardiovascular Health.” Registration is required.

Join the National Human Genome Research Institute (NHGRI) on Wednesday, May 25, from 1-3 p.m. ET for a conversation on the complexities surrounding historical and present-day eugenics, scientific racism and ableism in the context of genetic and genomic screening and diagnostic technologies.
Continue reading →

Register for the upcoming International HundredK+ Cohorts Consortium(IHCC) Educational Webinar on May 23, 2022 at 9am ET/1pm GMT.  Our guest speaker Dr. Mahdi Sheikh will present his talk on “A journey from opium research to the opioid cohort consortium (OPICO)”. To learn more and to register, please visit the Educational Webinar page on the IHCC Website.

Registration is required. Register here.

During the second annual Public Health Genetics Week, we will be celebrating the efforts of those individuals who participate in the public health genetics system and seek to raise awareness about the field. Learn more about virtual events to attend>>

The Duke Margolis Center for Health Policy, in collaboration with the FDA, is convening a virtual two-day workshop May 24-25 from 12pm ET – 4pm ET, titled “Translational Science in Drug Development: Surrogate Endpoints, Biomarkers, and More.” This workshop will be of key relevance to a wide array of faculty, staff, and students working in basic, translational, and clinical sciences that support the development of therapeutics.

Register here: https://healthpolicy.duke.edu/events/translational-science-drug-development-surrogate-endpoints-biomarkers-and-more

For any questions about the workshop, please feel free to reach out to Erin Soule or Nancy Allen Lapointe.

Register to attend the upcoming ELSIconversations discussion, titled “Utility of Population Descriptors in Clinical Genetics.”

Register Here

When: May 6, 2022 from 12:00-1:00 pm ET/9:00-10:00 am PT

Question: What is the most important information, conceptually, for clinical genetics professionals to do their jobs well? Is the information always necessary; if not, when is it critical vs. extraneous? When is it potentially harmful?

Goal: Distill the most relevant information among population descriptors that serves a purpose in the clinical curation pipeline, or other clinical genetics work

Speakers:

• Carlee Dawson, BA: Diversity Measures in Genomic Medicine
• Dee McKnight, PhD: How Race, Ethnicity, and Ancestry Information is Used in Genetic Diagnostics: One Lab’s Perspective
• Julia Gimbernat-Mayol, MEng: Clinical Genetics Laboratories Use Divergent Demographic Frameworks Across Countries

Moderator: Shoumita Dasgupta, PhD

Please watch the above videos before attending the discussion (click on each title next to speaker names above to access the video). During the session, the presenters will answer questions about their research and take part in an open discussion with all attendees. Please bring your questions, join the discussion, and expect to network with your colleagues. We hope you will make new connections and start new conversations on ELSI research.